News & Events

Recent advances in several unrelated fields -- miniature mass spectrometry; artificial intelligence; and drug databases – may soon radically increase the ability of public-health workers to assess the chemical composition of pharmaceutical products rapidly, cheaply, and β€œin the field.” This potential, in turn, offers a variety of ways in which vaccines and medicines could be distributed more efficiently to poor patients in developing countries. William Fisher will discuss these possibilities and a pilot project in Namibia designed to test them.

Global Access in Action: Conversations in Global Health, Innovation, & the Digital World

Date
June 12, 2017
Time
12:00 pm - 1:30 pm
Pre-registration required?
Yes
Registration closed?
No

Location:

Harvard Global Health Institute Conference Room (42 Church St. Cambridge, MA 02138)

Description:

Speaker: William Fisher,  WilmerHale Professor of Intellectual Property Law and Faculty Director,  Berkman Klein Center for Internet and Society

Recent advances in several unrelated fields -- miniature mass spectrometry; artificial intelligence; and drug databases – may soon radically increase the ability of public-health workers to assess the chemical composition of pharmaceutical products rapidly, cheaply, and “in the field.”  This potential, in turn, offers a variety of ways in which vaccines and medicines could be distributed more efficiently to poor patients in developing countries. William Fisher will discuss these possibilities and a pilot project in Namibia designed to test them.

Register here.